Hytrin and Apresoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hytrin (terazosin hydrochloride) and Apresoline (hydralazine hydrochloride). Common drug interactions include disorientation among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Hytrin and Apresoline. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Hytrin?

Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 7,501 Hytrin users. Check the latest studies of Hytrin.

What is Apresoline?

Apresoline has active ingredients of hydralazine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,475 Apresoline users. Check the latest studies of Apresoline.



On Jul, 25, 2026

29 people who take Hytrin and Apresoline together, and have interactions are studied.

Hytrin and Apresoline drug interactions.

What are the common drug interactions of Hytrin and Apresoline, by gender? *:

female:

  1. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  2. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  3. Drug administration error
  4. Dysarthria (speech disorder)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Dysuria (painful or difficult urination)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Flat affect (absence of emotional response to a situation)
  10. Fluid intake reduced

male:

  1. Diarrhoea
  2. Pain
  3. Full blood count decreased
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Renal failure (kidney dysfunction)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Depression
  9. Emotional distress
  10. Fear

What are the common drug interactions of Hytrin and Apresoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Acute respiratory failure
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Hypokalaemia (low potassium)
  6. Laryngeal oedema (swelling of larynx)
  7. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Urinary tract infection

50-59:

  1. Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia)
  2. Ischaemic cerebral infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain)
  3. Chronic kidney disease
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)
  7. Abdominal pain upper
  8. Renal injury (kidney injury)

60+:

  1. Diarrhoea
  2. Pain
  3. Full blood count decreased
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Chronic kidney disease
  8. Depression
  9. Emotional distress
  10. Fear

What are the existing conditions these people have? *

  1. Pain: 7 people, 24.14%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 20.69%
  3. Acute Kidney Failure: 4 people, 13.79%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 13.79%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 13.79%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 13.79%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.79%
  8. Renal Cell Carcinoma (a kidney cancer): 3 people, 10.34%
  9. Itching: 3 people, 10.34%
  10. Nausea (feeling of having an urge to vomit): 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Hytrin and Apresoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hytrin and Apresoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hytrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Apresoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hytrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apresoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on terazosin hydrochloride and hydralazine hydrochloride (the active ingredients of Hytrin and Apresoline, respectively), and Hytrin and Apresoline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: